CRIS Current Research Information System

GRIGIONI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.005
AS - Asia 3.516
EU - Europa 2.479
SA - Sud America 196
AF - Africa 182
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.968
SG - Singapore 1.035
VN - Vietnam 1.033
CN - Cina 814
GB - Regno Unito 629
DE - Germania 365
SE - Svezia 326
HK - Hong Kong 232
FR - Francia 207
IT - Italia 198
RU - Federazione Russa 152
UA - Ucraina 149
IN - India 148
BR - Brasile 146
IE - Irlanda 113
NL - Olanda 100
CH - Svizzera 62
JP - Giappone 49
TG - Togo 49
ZA - Sudafrica 48
EE - Estonia 44
KR - Corea 44
FI - Finlandia 39
CI - Costa d'Avorio 35
BE - Belgio 28
JO - Giordania 28
SC - Seychelles 24
TH - Thailandia 22
AR - Argentina 21
CA - Canada 21
BG - Bulgaria 19
PH - Filippine 19
IQ - Iraq 15
IR - Iran 14
MX - Messico 12
NG - Nigeria 12
PL - Polonia 10
BD - Bangladesh 9
PK - Pakistan 8
TW - Taiwan 8
CL - Cile 7
ES - Italia 7
GR - Grecia 7
EC - Ecuador 6
ID - Indonesia 6
MY - Malesia 6
AT - Austria 5
CO - Colombia 5
RO - Romania 5
TR - Turchia 5
PY - Paraguay 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
LB - Libano 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
HR - Croazia 2
KE - Kenya 2
NO - Norvegia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
GN - Guinea 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
QA - Qatar 1
RW - Ruanda 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 10.383
Salva come PNG Salva come JPEG
Città #
Singapore 682
Southend 542
Ashburn 406
Fairfield 387
Chandler 328
Hong Kong 222
San Jose 221
Woodbridge 212
Ho Chi Minh City 198
Dong Ket 185
Wilmington 183
Seattle 178
Houston 168
Hanoi 163
Princeton 161
Ann Arbor 149
Cambridge 147
Santa Clara 117
Dublin 113
Hefei 105
Jacksonville 105
Beijing 103
Boardman 101
Lauterbourg 80
Berlin 67
Los Angeles 60
Bern 57
Nanjing 51
Westminster 51
Padova 50
Lomé 49
Tokyo 44
Dallas 42
Abidjan 35
Haiphong 35
Helsinki 34
Saint Petersburg 34
Jinan 33
Frankfurt am Main 31
Seoul 31
Bologna 30
Amman 28
New York 28
Bremen 27
Brussels 27
Buffalo 27
Shenyang 25
Guangzhou 24
Redmond 23
San Diego 23
Redondo Beach 22
Tianjin 20
Changsha 18
Da Nang 18
Munich 18
Mülheim 18
Nanchang 18
Sofia 18
São Paulo 18
Dearborn 17
Chicago 15
Milan 15
Shanghai 15
Des Moines 14
Turin 14
Mahé 13
Haikou 12
Orem 12
Abeokuta 11
Falkenstein 11
Hải Dương 11
Paris 11
Baghdad 10
Bangkok 10
Brooklyn 10
Florence 10
Hebei 10
Zhengzhou 10
Falls Church 9
San Francisco 9
Toronto 9
Jiaxing 8
Norwalk 8
Redwood City 8
Bengaluru 7
Can Tho 7
Düsseldorf 7
Elk Grove Village 7
Kunming 7
London 7
Medford 7
Montreal 7
Ningbo 7
Ninh Bình 7
Nuremberg 7
Roubaix 7
Shijiazhuang 7
Thái Bình 7
Verona 7
Warsaw 7
Totale 6.784
Salva come PNG Salva come JPEG
Nome #
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 322
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 236
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 232
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 229
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 227
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 213
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 207
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 204
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 204
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 202
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 200
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 199
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 194
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience 189
Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. 180
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 178
Efficacy and appropriateness of histological score in prediction of the 3-year outcome of kidney transplantation 176
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer 176
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. 174
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 174
Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. 171
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 168
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 167
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 166
Portal vein arterialization: a new surgical option against acute liver failure? 165
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 163
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 163
Characterization of small nodules in liver cirrhosis. The assessment of the vascular pattern at imaging techniques. The problem of "hypovascular" HCC 161
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 159
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. 155
Histopathological evaluation of recurrent hepatitis C after liver transplantation: A review 151
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 151
Endoscopic finding of granular cell tumour associated with leiomyomas in the oesophagus. 143
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study. 143
A novel spectral ultrasonic differentiation method for marking regions of interest in biological tissue: in vitro results for prostate. 138
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. 130
Expression of beta-galactoside alpha 2,6 sialyltransferase and of alpha 2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis 130
Strategies for evaluation of suitable donors: Italian experience. 129
Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. 128
Toward the definition of immunosuppressive regimens with antitumor activity. 122
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. 120
Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. 120
Endothelial cell differentiation in hepatocellular adenomas:implications for histopathological diagnosis. 119
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. 117
Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period. 115
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. 115
Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy. 112
Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients 108
Italian Transplant Research Network. The Italian multiorgan donor cancer screening protocol: 2002-2005 experience. 101
Insulin-like growth factor (IGF) stimulation of hepatocellular carcinoma (HCC) migration is mediated by divergent regulation of aspartyl-asparagyl B hydroxylase (AAH) and notch 101
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma: An in situ hybridization and immunohistochemical study 100
Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma 91
A multiorgan donor cancer screening protocol: The Italian Emilia-Romagna region experience 90
Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor 86
Role and new perspectives of transforming growth factor-α (TGF-α) in adenocarcinoma of the gastro-oesophageal junction 86
High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas 85
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: An immunohistochemical and in situ hybridization study 81
Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas 81
Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis 80
Expression of insulin‐like growth factor II (IGF–II) in human hepatocellular carcinomas: An immunohistochemical study 80
Expression, regulation, and function of αV integrins in hepatocellular carcinoma: An in vivo and in vitro study 78
Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: An immunohistochemical study on 109 Italian patients 76
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane 72
Factors affecting recurrence in Crohn's disease: Results of a prospective audit 71
Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma 70
Discrepancies between detection of Bcl-2 by in situ hybridization and immunocytochemistry in human prostate cancer tissues 69
Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection 67
Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation 59
Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours 56
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c- met does 56
The metabolic organization of the adult human liver: A comparative study of normal, fibrotic, and cirrhotic liver tissue 50
Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules 50
Focal nodular hyperplasia of the liver: Composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules 48
Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease 47
Expression of cadherins and α-catenin in primary epithelial tumors of the liver 46
Space-occupying (malignant) lesions of the liver 44
Low p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinoma 43
Benign lesions of the liver 37
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 33
Early-stage focal nodular hyperplasia: US/CT/MR features correlated with histology 23
Totale 10.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.196
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021344 0 0 0 0 0 0 0 0 0 37 38 269
2021/20221.286 202 29 85 119 93 44 28 67 31 62 355 171
2022/20231.410 187 213 72 169 89 96 39 80 254 28 96 87
2023/2024281 27 70 16 26 21 47 14 21 8 13 9 9
2024/20251.457 37 285 140 117 213 87 63 29 17 128 31 310
2025/20263.080 269 292 369 254 355 201 295 119 742 184 0 0
Totale 10.505